Author Archive for: panglobal

About panglobal

This author has yet to write their bio.

Entries by panglobal

Siemens Healthineers unveils Acuson Origin – a premium ultrasound system for cardiovascular procedures

10 October 2023 in Product News /by panglobal

Siemens Healthineers has unveiled the Acuson Origin, a dedicated cardiovascular ultrasound system with new, powerful artificial intelligence (AI) features. Designed to improve patient outcomes and help physicians perform minimally invasive cardiac procedures more efficiently, the Acuson Origin addresses the entire continuum of cardiovascular patient care, including diagnostic, structural heart, electrophysiological, and paediatric procedures.

Hemosonics introduces Quantra POC device for managing high-risk bleeding

10 October 2023 in Product News /by panglobal

Hemosonics’ Quantra System is a novel point-of care (POC) device for the management of high-risk bleeding, especially in cardiothoracic surgery, trauma, orthopaedics and liver transplantation.

Leading Cambridge neuroscientist appointed as Executive Chair of UK’s Medical Research Council

10 October 2023 in E-News /by panglobal

The UK’s Secretary of State for Science, Innovation and Technology, Michelle Donelan, has appointed Professor Patrick Chinnery as the next Executive Chair of the Medical Research Council (MRC). He will succeed the current interim Executive Chair of MRC, Professor John Iredale and is expected to start in October. “Professor Chinnery brings a wealth of experience […]

Bio-Gate partnership  Hologic and Bayer set up international partnership to provide contrast-enhanced mammography package

10 October 2023 in E-News /by panglobal

Hologic and Bayer has established an international partnership to deliver contrast-enhanced mammography (CEM) solutions to improve the detection of breast cancer for women in multiple countries across the European, Canadian and Asia Pacific regions.

Eshelman Institute for Innovation establishes research collaboration  with Aston University

10 October 2023 in E-News /by panglobal

As part of a new collaboration, the Eshelman Institute for Innovation  (EII), within the UNC Eshelman School  of Pharmacy, in North Carolina, US, will work with Aston University, in Birmingham, England, on a three-year project focused on preventing damage caused by swelling of the central nervous system (CNS).

Surrey and Sussex collaborative extends Sectra imaging technology to sixth NHS trust

10 October 2023 in E-News /by panglobal

Surrey and Sussex Healthcare NHS Trust has signed a new agreement to deploy Sectra’s enterprise imaging solution in  bid to further improve patient care.

AI in BioMed forecast to reach $6 trillion by 2027

10 October 2023 in E-News /by panglobal

The most comprehensive mapping of companies, investors, trends, technologies and industry leaders in the AI in BioTech and HealthTech Industry Ecosystem [1] – 14,000 organizations in total – was released recently by Global AI Ecosystem, with the support of AI Industry Analytics (AiiA) and Deep Knowledge Group.

ESC publishes first guideline covering all acute coronary syndromes

10 October 2023 in Featured Articles /by panglobal

The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are were published online 25 August 2023 in the European Heart Journal [1]. The document covers the management of unstable angina and all types of acute myocardial infarction.

ESC publishes international guidelines on cardiomyopathies

10 October 2023 in Featured Articles /by panglobal

The European Society of Cardiology (ESC) published Guidelines on cardiomyopathies on 25 August 2023 in European Heart Journal. [1] This is the first international guideline document to include all cardiomyopathy subtypes, and the first time that specific recommendations are made for cardiomyopathies other than hypertrophic cardiomyopathy.

Intravascular imaging associated with improved outcomes compared with angiography

10 October 2023 in Featured Articles /by panglobal

ESC Congress 2023 Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided PCI, according to research presented at the ESC Congress 2023.

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.